This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Dexmedetomidine Combined With Transcutaneous Vagus Nerve Stimulation (taVNS) Can Reduce the Incidence of PTSD in Trauma Patients After Surgery | MicrobiomeTrials
← Back to trials NCT07813962
Dexmedetomidine Combined With Transcutaneous Vagus Nerve Stimulation (taVNS) Can Reduce the Incidence of PTSD in Trauma Patients After Surgery Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-09-06Est. Completion: 2027-08-01
Enrollment target: 300 participantsOther microbiome trials you might be interested in Psychological Trauma Stress Disorders, Post-Traumatic; Mental Disorders
Psychological trauma is common and can lead to long-lasting emotional distress, difficulties in daily functioning, and r…
Barcelona, Spain Est. completion Oct 2028
Opioid Use Disorder
VA-BRAVE will determine whether a 28-day long-acting injectable sub-cutaneous formulation of buprenorphine at a target d…
Tuscaloosa, United States Est. completion Sep 30, 2028
Chronic Pain PTSD
The primary aim of this study is to investigate the effect of Internet-delivered Acceptance and commitment therapy for y…
Lund, Sweden Est. completion Dec 31, 2027